ҽҩ֪ʶ
ҽҩ֪ʶ
ҽҩ֪ʶ
ҽҩѶ
  • KҩϻٰЧ鵥ԮĿ

    ָٰٰУԼ15%-20%ٰߴƼ壨ERм壨PR˱Ƥ2HER2ΪԡδЩ壬޷ܰЩİƷƣѡޡٰյһٰϮǿתơԤ󼫲ȷͨ20£5ʲ15%Kҩ˴μ׼ǻΪKEYNOTE-3553ٴĽһУܼ323PD-L1TNBC߽Keytruda뻯ƹɵƷο뻯ƹɵ

  • θҩЧԣ

    θGISTһɻĺθռθ 0.13Ϊ 11.5/10GISTIJвû֪ĵGISTʽأʳ̣ӻKITPDGFRA򼤻ͻ¡ᡢֱθGISTһҩPDGFRA18ͻ䣬D842VͻĻ߶аҩﲻУ໼Ⱥҩѷڶͻ伤ø͵ķо߿ǿЧѡԵĢKITPDGFRAͻƼᣬ

  • AamivantamabLazertinibEGFRͻСϸΰЧ

    2020ŷڿѧᣨESMOϵı1CHRYSALISʾδԼϣҩEGFRͻڷСϸΰУAamivantamabLazertinibʾЧáδƵĻߣλ7ʱ͹ۻʣORRٴʣCBRΪ10020ֻ⣨PRڰϣҩδƵĻߣλ4ʱ͹ۻΪ361ȫ15ֻ⣬Լ1дȷϵIJֻ⡣ٴΪ60AmivantamabһEGFR-MET˫Կ壬Ǵҳ

  • NMPAʾ鵥ɼٰƵЧԺDZڰȫ

    ʳƷҩƷ֣FDAڷȫԹͨϢʾҽԱٴоԼߣһٴʾ֮ǰûнܹơ޷ľֲڻתٰmTNBCߣ鵥atezolizumabƷTecentriq̩ʥ棩ɼƲܷáFDAδ׼鵥ɼٰƣ׼鵥ϰ׵׽ɼƷAbraxanePD-L1ijٰߵơٴʵУҽԱɼ׵׽ɼ˴

  • Ƽ״ٰЧ2020ҽ۸

    ״MTCһֶԳ̶ȽϸߡԤϲİ֢Ŀǰ MTC ҪͨΪȻڷչһ׶κ󣬻޷ƣͬʱԻƲУȱЧҩˣڽϴδ󡣡ڱλļ״Ӧ֢ٴ¶ 2019 ASCO ᡣһڰ MTC ˫äοٴоNCT02586350У 91 顣ʾӳߵ޽չ棨PFS9.6 £20.67 ¶ 11.07 £͹ۻʣO

  • ٰЧЩҩ۸Ƕ٣

    ٰЧôأٴУЯŴBRCAͻٰߵһߺƵάơ154飬3:2飬οƣֱչƽǣλ޽չ7.4£ο3.8£ٰ޽չӳ1üչս47%⣬Ƶٰߣ12޽չڰο飬ֱΪ33.7% vs 14.5%22.1% vs 9.6%˵ûߡĿ

  • ٰһҩʲôЧ

    ٰһֶԳ̶Ⱥܸߣ֮ϺƶѵԼ90%ΪԴٹƤĵٰʽٰȷʲߣʽϸߣʺܵ͡2021ٴѧθֻᣨASCO GIArcus Biosciences˾AB680תٰI/IbоARC-8ֵijݣ˸⾪ϲʾĿǰΪֹAB680뻯ƺͿPD-1ãƵĿ͹ۻʣORRΪ41%뵱ǰı׼бȽϴԽԡʲôAB680AB6

  • Ƭǰٰ2020ҽ

    գƬӦ֢ҩЯBRCA1/2ͻ䣨ϵ/ϸϵڼͼҩƺּչתȥƵֿǰٰ˻ߡFDA׼׸ڷնǾۺø(PARP)ƼͨPARPøԺͷֹPARPDNA룬ЭͬDNA޸ȱݣɱϸ2014Ⱥŷ˺С20188״λNMPA׼УֹĿǰڹڻƣٲеĸƤѳѹܰԭԸĤ˻ں

  • Ī«θйݽ룬Ī¬ѻӦ֢Щ

    θҹ3ߵĶ2020ҹ·θԼΪ48Լռȫ·θ44%2020ҹθ37ռȫθһ롣գVEGFR2RamucirumabĪ«NMPAԤ걨Ӧ֢ΪθθʳܽϲٰơĪ«ȫ׸ΪֹΨһθ/θʳܽ紦Ʒ2014꣬Ī«ڻתθθʳܽϲٰ2021112գĪ«ϻɼƾϷ

  • 2020ҽĿ¼ƻϾ򵰰Ѫ֢ЧΣ

    2020ҽĿ¼ޣ1.ٽܹһƵϸܰ MCLߵƣ2.ܰϸѪ/СܰϸܰCLL/SLLߵƣ3.Ͼ򵰰Ѫ֢ߵƣ˵ҩ ЭЧڣ20213120221231ա棨ᣩImbruvicaibrutinibΪ³ᣬһֿڷ³ҰἤøBTKƼiNNOVATEоҪݣ2015ΪҩƷWMΪ1ҲΨһ1FDA׼WMҩ2018꣬

  • ҩRinvoqƻмؽ׺ͻǿֱԼ׻ߵЧ

    ŷҩƷ֣EMAҽҩƷίԱᣨCHMPѷһݻƼ׼Rinvoqupadacitinib2µķʪӦ֢ƻмؽףPsA˻ߺͻǿֱԼףAS˻ߡRinvoqһֿڷÿһεġѡԡJAKƼŷ˺ŷˣRinvoq֮ǰѱ׼жضʪԹؽףRA˻ߡRinvoqPsAӦ֢룬2IIIٴоSELECT-PsA-1NCT03104400SELECT-PsA-2NCT03104374֧֡2о˳2000PsA

  • Գڷ𣿰Щ

    ڿڷЧӺάƢгƢгδгƢࣨδгƢij껼ߵѪСITPһֺDZڵѪҺѪС٣ѪҺᡣ߻ˣѪijЩ»ᷢصijѪġITPҲܻӰ컼ߵΪͨƣͺ;ɥԼԳѪĿ־壨ճءEXTENDЧڰƵڣѪСλ=50109/LѪСλ50109/LάϡϺ

  • ڳ˻еЧӡаҩ

    ϵijʱ䣬ITPΪԣ0-3£3-12£ԣ12£/־ITP׷ڳУŮԻƵԵ/ITPĿάְȫѪСԼٳѪķաȡ֢״س̶ȡڴ£й涨˸ıϵͳѪСĹҩ԰Ƴ˵ijѪˡeltrombopagڻ/ѪС֢ITPijеĻȫԺЧԡΪһֵѡԳڻ

  • ӦȺӡȰϼʲôͬ

    һֵʵʽܹѪС壨ѪҺϸɡͨѪҺеѪСͳѪաƾƤʼҩ򵰰ЧƢгطѪС񰣨ITPߵѪС١ҩ1ϵij˺ͶֻͯӦITPѪСٳ̶ٴӳѪյĻߡԤøƵԱ͸׳˵ѪСٵҩﳢʧܺ󣬰ҲƳصϰƶѪԭҩ

  • ȣ䵥NSCLCʸߣӦʵͣ

    III(CheckMate 017CheckMate 057)У䵥ȣɽһ߼ƹ״ͷ״NSCLCߵܴ(OS)ҰȫҲá鹲854λNSCLCߣECOG PS 1һ߲ΪĻƹ/˽չΪ飬ֱ䵥(3 mg/kg1/2)(75 mg/m1/3)ƣֱչֲɽܵĶԡҪյ㶼OSҪյ޽չ(PFS)ͰȫԡCheckmate 017057ֱʱ64.264.5º󣬽

  • йУЧô

    2020429գFDA׼ΪһֵҩάƷڶһߺȫ򲿷ֻѳѳƤѹܰԭԸĤŮԻߣ־״̬Ρ2020910գٶҽҩҩƷලѾ׼IJҩ룬ƤѳѹܰԭԸĤ˻߶һߺƴﵽȫ򲿷ֻάơٴݡ˫äοյIIIУ733ߣ2:1飬ֱᣨn = 487ο

  • Чעϼҩ۸

    2016629գTESAROZejulaڻƺ󸴷ѳIIIٴݣʾBRCAͻѳÿտڷZejulaһΣλ޽չΪ21£(ʹû)IJˣֻ5.5£ǰǺߵĽӽ4δͻ仼ߣҲ9.3£οעЩ?1.쳣ۺ/Թ԰Ѫ(MDS/AML)MDS/AMLڱ¶ZEJULAĻУЩķġ⻼ߵѪҺԲȷMDS/AMLʱֹͣʹá2.

  • 鵥ܸMSI-H/dMMRתԽֱߵPFS

    KEYNOTE-177һIIIűǩٴоּһ鵥ơ鵥ƣ΢Ǹ߶Ȳȶ/޸ȱݣMSI-H/dMMRתԽֱmCRCЧоECOG0-1֡MSI-H/dMMR mCRCߣ1:1鵥200mgQ3W2꣩оѡmFOLFOX6FOLFIRI鵥ֱչֲܵĶԣ/о˳о黼߼չɽ鵥顣ҪյΪ޽չڣPFSRECIST1.1

  • FDA׼EnhertuθθʳٰЧô

    Enhertutrastuzumab deruxtecanDS-8201 DzõһרеDXd ADCƵĿżҩɰHER2Դ¡ͨһһ칹ø1ƼӶɡHER2һҰἤø壬УٰθͽֱFDAգ˹͵һEnhertufam-trastuzumab deruxtecan-nxkiӦ֢Χ԰ǰѽܹ鵥ƵľֲڻתHER2θθʳܣGEJٰFDA2019׼˿-ҩżEnhertuǰ

  • ҸβЯдȾҸЯҪҪƣ

    й1.2ҸβЯߣӴȺ屻ڳڵУȻһشɻرܵ⡣Щվڡ桱ĽǶȷŴҸεĴȾԺͲӰ죬ҸβЯ߽ų⣬ܶಡЯְѧȷȨòϣǾ޴ѹʹ䲡񻯡ҸЯߵЩ¶ҸβЯдȾ𣿡ҸβЯߣָѪҺⵥ͸ױ濹ԭԣ޸֢״ιܼ۲ޱ仯ߡһΪ

共有86页首页上一页123456789下一页尾页
客服中心
联系方式
400-001-9763
- ѯ
ɨάѯ